|
|
||||||||
Ann Thorac Surg 2000;70:1119-1123
© 2000 The Society of Thoracic Surgeons
a Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany
Address reprint requests to Dr Harringer, Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg-Str 1, 30625 Hannover, Germany
e-mail: harringer{at}thg.mh-hannover.de
Presented at the Sixth Annual Cardiothoracic Techniques and Technologies Meeting 2000, Ft Lauderdale, FL, Jan 2729, 2000.
| Abstract |
|---|
|
|
|---|
Methods. A prospective registry of 304 patients was initiated to describe patient selection, procedures, particulate capture, and clinical outcomes after intraaortic filtration in patients undergoing cardiac surgical procedures with cardiopulmonary bypass and median sternotomy. Prior to the removal of the cross-clamp, the intraaortic filter (EMBOL-X Inc, Mountain View, CA) was deployed and left in place until the patient was weaned from extracorporeal circulation. Upon removal, filters were fixed in formalin and shipped to a core laboratory for examination.
Results. Mean patient age was 68 years (range 25 to 88 years), 40% had ascending aortic calcification, 59% of the procedures were coronary artery bypass grafting (CABG), 20% were valve replacement or repair, and 12% were a combination of CABG and valve surgery. Aortic cross-clamps were used in nearly all cases (302 of 304 patients); partial clamps were used in 84% of the CABG procedures. To date, 243 filters have been examined. Sixty-two percent of the filters analyzed revealed fibrous atheroma, 2% grumous atheroma, and 6% epiaortic debris. Platelet and fibrin strands were found in 52% of the filters and 22% contained evidence of thrombus or red blood cells.
Conclusions. These findings from the International Council of Emboli Management Registry confirm that particulates are released during cardiac surgical procedures using the aortic cross-clamp. Continued observational and randomized studies are necessary to confirm the clinical relevance of particulate extraction.
| Introduction |
|---|
|
|
|---|
In 1996, Roach and colleagues [3] published the results of a landmark study enrolling 2,417 patients who underwent elective coronary artery bypass grafting (CABG) to assess the incidence of adverse perioperative cerebral outcomes. Perioperative adverse cerebral outcomes affected 6.1% of the patients with 3.1% classified as type I injury (death due to stroke or hypoxic encephalopathy, nonfatal stroke, transient ischemic attack, stupor, or coma at the time of discharge) and 3.0% classified as type II injury (new deterioration in intellectual function, confusion, agitation, disorientation, memory deficit, or seizure without evidence of focal injury). Patients with adverse cerebral outcomes had 5 to 10 times the mortality, 2 to 4 times the time spent in intensive care, and 3 to 6 times the need for prolonged care when compared with patients without neurologic injury. In addition, it was clearly demonstrated that the single most important risk factor for adverse neurologic events was the presence of proximal aortic atherosclerosis as determined by surgical palpation. In a subsequent study of 273 patients who underwent intracardiac and coronary artery surgical procedures, it was further demonstrated that significant risk factors for type I outcomes are related primarily to embolic phenomena, including proximal aortic atherosclerosis, intracardiac thrombus, and intermittent clamping of the aorta during operation [4].
Additionally, Barbut and coworkers [57] were able to demonstrate a strong correlation between the severity of aortic atheroma and amount of emboli released, utilizing transcranial Doppler (TCD) and transesophageal echo (TEE). They were also able to demonstrate that most emboli (60%) are released during clamp manipulation of the ascending aorta, primarily following cross-clamp removal [57]. It was thus hypothesized that the use of an intraaortic filter during cardiac operation should reduce neurologic injury.
To answer this question, the International Council of Emboli Management (ICEM) (see Appendix) established a prospective, consecutive enrollment, multiinstitutional registry of patients in whom intraaortic filtration has been used during cardiopulmonary bypass (CPB).
| Material and methods |
|---|
|
|
|---|
|
Upon removal, filters were visually inspected for captured material, collected in specimen tubes, fixed in formalin, and shipped to a central pathology laboratory (Stanford University, Stanford, CA) for further analysis. Filter analysis included gross visual examination (10x magnification) to determine the quantity and size of the particulate captured, as well as histologic examination (stains with hematoxylin and eosin, trichrome, and Elastica van Gieson) for the presence of platelets and fibrin deposition, true thrombus or blood clot, grumous portion of atheroma/cholesterol, fibrous atheroma or fibrous cap, medial tissue, and epiaortic debris.
| Results |
|---|
|
|
|---|
|
Filter deployment was simple and successful in all patients. There were no filter-related adverse events nor were there any incidences of aortic dissection. Consistent with the risk profile of the study population, there were 16 (5.7%) deaths. Short transient delirium ranging from 24 to 48 hours was reported immediately postoperatively in 9 patients (3.2%). The registry showed 1 patient with a transient ischemic attack (0.36%), 2 patients with stroke (0.71%), and 1 patient with a coma (0.36%).
Hard granular particulate or soft material was seen upon visual examination in 240 of the 243 filters (99%) (Fig 2). Mean number of particles per filter was 8.2 (range 0 to 35) and mean surface area of particles per filter was 7.7 mm2 (range 0 to 67 mm2). Histologic examination differentiated the captured particulate into presence or absence of platelet/fibrin deposition, true red blood cell thrombus (blood clot), grumous atheroma, fibrous atheroma or fibrous cap (with or without calcification or grumous/cholesterol), and medial tissue. Fibroatheromatous material, including needle-shaped cholesterol fragments and atheroma, was the type of particulate most often found in the 243 filters examined. Fibrous atheroma or fibrous cap was present in 62% (151 of 243) of the filters. Fibrin, with and without the obvious presence of platelets, was present in 52% (127 of 243) of the filters, and true thrombus (including clot rich with erythrocytes) was present in 22% (54 of 243) of the filters. Medial tissue was present in 4% of the filters and grumous portion of the atheromatous plaque was found in 2% (4 of 243) of the filters. Mature hyaline cartilage, suture material, and fat was also found (Table 2).
|
|
| Comment |
|---|
|
|
|---|
Although previous studies have clearly documented the existence and impact of embolic release during cardiac operation, all of these studies have been limited by the fact that embolic activity is measured indirectly through TEE or TCD. Clinical events caused by emboli are difficult to prove without autopsy analysis. Further, neither TEE nor TCD have been able to reliably distinguish between particulate and gaseous material. The data from the ICEM Registry provide direct evidence that atheromatous material released from the aorta during surgical procedures is present in most cardiac procedures and that this material can be effectively removed before entering into distal circulation. Using TEE and TCD to determine emboli size, Barbut and colleagues [6] reported that 72% of emboli measured more than 600 µm in diameter (28% more than 1,000 µm and 44% between 600 and 1,000 µm), and 27% measured 600 µm or less in diameter. The 120-µm mesh of the filter is sized significantly smaller than most emboli released.
Although the ICEM data clearly demonstrate the efficacy of intraaortic filtration in capturing and removing particulate debris, the clinical impact of particulate removal remains a crucial question. Patients enrolled in the ICEM Registry had at least equivalent if not higher risk profiles than those studied in the Roach and colleagues prospective observational study [3]. Presence of aortic atheromatosis (Roach 12.4%; ICEM 16.6%), history of neurologic events (Roach 8.3%; ICEM 10.7%), age greater than 70 years (Roach 31.9%; ICEM 53.9%), hypertension (Roach 57.2%; ICEM 62.68%), and diabetes (Roach 25.1%; ICEM 18.3%) have all been identified as predictors of adverse neurologic events. In addition, whereas the Roach study was limited to CABG patients only, the ICEM group includes all procedures in which an aortic cross-clamp is used, such as valve, combination CABG/valve, and other procedures.
Although the ICEM Registry population included patients at higher risk, the incidence of stroke in the ICEM group (0.7%) was surprisingly low. In the ICEM Registry, all type I outcomes were significantly lower (1.4%) than those reported in the Roach study (3.1%) [3]. Of the 2 patients who had a stroke in the ICEM Registry group, the first patient died on postoperative day 2 after remaining in a coma following a combined aortic valve replacement and carotid endarterectomy. In the second case, the patient presented with chronic atrial fibrillation, initially recovered normally, and on postoperative day 3 had a stroke. The patient who was in a coma was an urgent case presenting with multiple comorbidities, including preexisting stroke, delirium, memory deficit, peripheral neuropathy, cardiogenic shock, and diabetes and died on postoperative day 24 without regaining consciousness. In all of these cases, it is doubtful that the event experienced was related to particulate matter released perioperatively from the ascending aorta. Despite a reduction in focal neurologic injury in the ICEM Registry population, the benefit in improving type II outcomes (Roach 3.0%; ICEM 3.2%) was not evident. One could speculate that the pathogenesis of type II injuries after cardiac operation might be different from focal damages. Hypoperfusion, inflammatory response due to CPB, and anesthetic agents could play a greater role in patients with cognitive dysfunction.
Because the ICEM registry was not designed to test a specific hypothesis and does not encompass a control group, our ability to draw conclusions from these data is limited. Patient enrollment in this registry is still preliminary, and larger numbers will be needed to clarify conclusions from these data. In addition, a multicenter study on selected patients with a blinded neurologic analysis will be needed to confirm the significance of these trends.
Nevertheless, these data begin to validate the theory posted in previous studies that particulate matter released intraoperatively is a causative factor in permanent focal neurologic injury. Despite the current increase in off-pump coronary bypass operations, data emerging on neurologic outcomes have failed to demonstrate an improvement. This finding might reflect emboli release during partial aortic clamping, which was applied in most off-pump patients [9].
The ICEM data demonstrate the safety and clear efficacy of intraaortic filtration in capturing and removing particulate debris. In addition, the low rates of adverse type I outcomes may show a trend toward reduction of permanent focal neurologic injury related to removal of atheromatous emboli. Due to the structure of patient enrollment and data collection in a prospective registry, the clinical significance of intraaortic filtration should be evaluated further in a randomized prospective multicenter study. In the meantime, in patients at risk for adverse neurologic events and in whom the ascending aorta is manipulated during cardiac operations, intraaortic filtration is advisable.
| Footnotes |
|---|
|
|
|---|
| Appendix |
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
N = 243. No particulates were seen in 3 filters.
RBC = red blood cells.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. W. Hammon Extracorporeal Circulation: Perfusion System , January 1, 2008; 3(2008): 350 - 370. [Full Text] |
||||
![]() |
C.-A. Mestres, E. Bernabeu, C. Fernandez, A. Colli, and M. Josa Intra-aortic Filtration is Effective in Collecting Hazardous Materials Asian Cardiovascular and Thoracic Annals, April 1, 2007; 15(2): e33 - e34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D Raymond, M. Radel, M. J Ray, A. D Hinton-Bayre, and N. A Marsh Investigation of factors relating to neuropsychological change following cardiac surgery Perfusion, January 1, 2007; 22(1): 27 - 33. [Abstract] [PDF] |
||||
![]() |
J. Bonatti, W. J. van Boven, G. Nagele, G. Shahin, T. Schachner, G. Laufer, P. Bergman, J. van der Linden, and The AORTIC Study Group (Assessment Of the Risk of Do particulate emboli from the ascending aorta in coronary bypass grafting correlate with aortic wall thickness? Interact CardioVasc Thorac Surg, December 1, 2006; 5(6): 716 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boivie, M. Hansson, and K. G. Engstrom Intraluminal aortic manipulation by means of intra-aortic filter, cannulation, and external clamp maneuvers evaluated versus dislodged embolic material J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. P. Liew and J. R Bartholomew Atheromatous embolization Vascular Medicine, November 1, 2005; 10(4): 309 - 326. [Abstract] [PDF] |
||||
![]() |
P. Boivie, C. Edstrom, and K. G. Engstrom Side differences in cerebrovascular accidents after cardiac surgery: A statistical analysis of neurologic symptoms and possible implications for anatomic mechanisms of aortic particle embolization J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 591 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Doblar Intraoperative Transcranial Ultrasonic Monitoring for Cardiac and Vascular Surgery Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2004; 8(2): 127 - 145. [Abstract] [PDF] |
||||
![]() |
K. G. Engstrom Contaminating fat in pericardial suction blood: a clinical, technical and scientific challenge Perfusion, January 1, 2004; 19(1_suppl): S21 - S31. [Abstract] [PDF] |
||||
![]() |
C. Schmitz, S. Weinreich, J. White, I. Oengoeren, R. Schneider, D. Schneider, I. Speth, C. Pohl, and A. Welz Can particulate extraction from the ascending aorta reduce neurologic injury in cardiac surgery? J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schoenburg, B. Kraus, A. Muehling, U. Taborski, H. Hofmann, G. Erhardt, S. Hein, M. Roth, P. R. Vogt, G. F. Karliczek, et al. The dynamic air bubble trap reduces cerebral microembolism during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1455 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Scarborough, W. White, F. E. Derilus, J. P. Mathew, M. F. Newman, and K. P. Landolfo Combined use of off-pump techniques and a sutureless proximal aortic anastomotic device reduces cerebral microemboli generation during coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1561 - 1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hagl, N. Khaladj, M. Karck, K. Kallenbach, R. Leyh, M. Winterhalter, and A. Haverich Hypothermic circulatory arrest during ascending and aortic arch surgery: the theoretical impact of different cerebral perfusion techniques and other methods of cerebral protection Eur J Cardiothorac Surg, September 1, 2003; 24(3): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Banbury, N. T. Kouchoukos, K. B. Allen, M. S. Slaughter, N. J. Weissman, G. J. Berry, and K. A. Horvath Emboli capture using the Embol-X intraaortic filter in cardiac surgery: a multicentered randomized trial of 1,289 patients Ann. Thorac. Surg., August 1, 2003; 76(2): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boivie, M. Hansson, and K. G. Engstrom Embolic material generated by multiple aortic crossclamping: A perfusion model with human cadaveric aorta J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1451 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wimmer-Greinecker and On behalf of the International Council of Emboli M Reduction of neurologic complications by intra-aortic filtration in patients undergoing combined intracardiac and CABG procedures Eur J Cardiothorac Surg, February 1, 2003; 23(2): 159 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hessel II and L. H. Edmunds Jr. Extracorporeal Circulation: Perfusion Systems , January 1, 2003; 2(2003): 317 - 338. [Full Text] |
||||
![]() |
J. W. Hammon Jr. and L. H. Edmunds Jr. Extracorporeal Circulation: Organ Damage , January 1, 2003; 2(2003): 361 - 388. [Full Text] |
||||
![]() |
S Eifert, H Reichenspurner, T Pfefferkorn, B Baur, C von Schlippenbach, T E Mayer, G Hamann, and B Reichart Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgery Perfusion, January 1, 2003; 18(1_suppl): 55 - 60. [Abstract] [PDF] |
||||
![]() |
P. Bergman, L. Hadjinikolaou, and J. van der Linden Aortic atheroma is related to number of particulates captured by intra-aortic filtration in CABG Eur J Cardiothorac Surg, October 1, 2002; 22(4): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gerdes, T. Hanke, and H.-H Sievers Hydrodynamics of the new Medos aortic cannula Perfusion, May 1, 2002; 17(3): 217 - 220. [Abstract] [PDF] |
||||
![]() |
J. M. Murkin, W. D. Boyd, S. Ganapathy, S. J. Adams, R. C. Peterson, J. Morgan, and P. Lok Neuroprotection During CPB: From Mechanisms to Interventions Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2002; 6(1): 3 - 6. [Abstract] [PDF] |
||||
![]() |
A. Gerdes, T. Hanke, and H.-H Sievers In vitro hydrodynamics of the Embol-X cannula Perfusion, March 1, 2002; 17(2): 153 - 156. [Abstract] [PDF] |
||||
![]() |
D. J. Cook, K. J. Zehr, T. A. Orszulak, and J. M. Slater Profound reduction in brain embolization using an endoaortic baffle during bypass in swine Ann. Thorac. Surg., January 1, 2002; 73(1): 198 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Leyh, S. Fischer, W. Harringer, and A. Haverich Intraoperative acute type A dissection caused by an intra-aortic filter (EMBOL-X(R)) in a patient undergoing mitral valve re-replacement for acute endocarditis Eur J Cardiothorac Surg, January 1, 2002; 21(1): 100 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Murkin Attenuation of neurologic injury during cardiac surgery Ann. Thorac. Surg., November 1, 2001; 72(5): S1838 - S1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
International Council of Emboli Management (ICEM), C. Schmitz, and E. H. Blackstone International Council of Emboli Management (ICEM) Study Group results: risk adjusted outcomes in intraaortic filtration Eur J Cardiothorac Surg, November 1, 2001; 20(5): 986 - 991. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |